Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benza

Showing results (261-270 of 361) with videos related to

Pageof 37
Sort By:
JACC. Heart Failure|August 13, 2018
A Bayesian Model to Predict Survival After Left Ventricular Assist Device ImplantationManreet K Kanwar, Lisa C Lohmueller, Robert L Kormos, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cellsX N Li, H E Grenett, R L Benza, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Pulmonary arterial hypertension: epidemiology and registries]Michael D McGoon, Raymond L Benza, Pilar Escribano-Subias, et al.
American Journal of Therapeutics|January 8, 2026
Resistance to Antibiotics, Complications, and Mortality of Infective Endocarditis in a Consecutive Cohort of 178 CasesAlexandru Covaciu, Elena Bobescu, Valentina Benza, et al.
ERJ Open Research|January 10, 2024
Prognostic value of deep echocardiographic phenotyping in pulmonary arterial hypertensionStefano Ghio, Roberto Badagliacca, Mauro Acquaro, et al.
Journal of the American College of Cardiology|June 3, 2004
Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experienceRaymond L Benza, Gilbert J Zoghbi, Jose Tallaj, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
Journal of the American College of Cardiology|December 21, 2013
Pulmonary arterial hypertension: epidemiology and registriesMichael D McGoon, Raymond L Benza, Pilar Escribano-Subias, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 6, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionRaymond L Benza, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
Blood Advances|January 26, 2021
PPARγ increases HUWE1 to attenuate NF-κB/p65 and sickle cell disease with pulmonary hypertensionAndrew J Jang, Sarah S Chang, Changwon Park, et al.
Pageof 37

Showing results (261-270 of 361) with videos related to

Sort By:
Pageof 37
JACC. Heart Failure|August 13, 2018
A Bayesian Model to Predict Survival After Left Ventricular Assist Device ImplantationManreet K Kanwar, Lisa C Lohmueller, Robert L Kormos, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Genotype-specific transcriptional regulation of PAI-1 expression by hypertriglyceridemic VLDL and Lp(a) in cultured human endothelial cellsX N Li, H E Grenett, R L Benza, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Pulmonary arterial hypertension: epidemiology and registries]Michael D McGoon, Raymond L Benza, Pilar Escribano-Subias, et al.
American Journal of Therapeutics|January 8, 2026
Resistance to Antibiotics, Complications, and Mortality of Infective Endocarditis in a Consecutive Cohort of 178 CasesAlexandru Covaciu, Elena Bobescu, Valentina Benza, et al.
ERJ Open Research|January 10, 2024
Prognostic value of deep echocardiographic phenotyping in pulmonary arterial hypertensionStefano Ghio, Roberto Badagliacca, Mauro Acquaro, et al.
Journal of the American College of Cardiology|June 3, 2004
Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experienceRaymond L Benza, Gilbert J Zoghbi, Jose Tallaj, et al.
JAMA|April 29, 2004
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trialMihai Gheorghiade, Wendy A Gattis, Christopher M O'Connor, et al.
Journal of the American College of Cardiology|December 21, 2013
Pulmonary arterial hypertension: epidemiology and registriesMichael D McGoon, Raymond L Benza, Pilar Escribano-Subias, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 6, 2021
Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionRaymond L Benza, Hossein-Ardeschir Ghofrani, Ekkehard Grünig, et al.
Blood Advances|January 26, 2021
PPARγ increases HUWE1 to attenuate NF-κB/p65 and sickle cell disease with pulmonary hypertensionAndrew J Jang, Sarah S Chang, Changwon Park, et al.
Pageof 37